HK131293A - Pharmaceutical compositions containing drugs which are sparingly soluble in water or instable and methods for their preparation - Google Patents

Pharmaceutical compositions containing drugs which are sparingly soluble in water or instable and methods for their preparation

Info

Publication number
HK131293A
HK131293A HK1312/93A HK131293A HK131293A HK 131293 A HK131293 A HK 131293A HK 1312/93 A HK1312/93 A HK 1312/93A HK 131293 A HK131293 A HK 131293A HK 131293 A HK131293 A HK 131293A
Authority
HK
Hong Kong
Prior art keywords
instable
water
pharmaceutical compositions
sparingly soluble
preparation
Prior art date
Application number
HK1312/93A
Other languages
English (en)
Inventor
Ulrich Brauns
B W W Prof Dr Mueller
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6217510&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK131293(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HK131293A publication Critical patent/HK131293A/xx

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK1312/93A 1983-12-21 1993-11-25 Pharmaceutical compositions containing drugs which are sparingly soluble in water or instable and methods for their preparation HK131293A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833346123 DE3346123A1 (de) 1983-12-21 1983-12-21 Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
HK131293A true HK131293A (en) 1993-12-03

Family

ID=6217510

Family Applications (1)

Application Number Title Priority Date Filing Date
HK1312/93A HK131293A (en) 1983-12-21 1993-11-25 Pharmaceutical compositions containing drugs which are sparingly soluble in water or instable and methods for their preparation

Country Status (17)

Country Link
EP (1) EP0149197B2 (fr)
JP (1) JPS61500788A (fr)
AT (1) ATE51145T1 (fr)
AU (1) AU565966B2 (fr)
CA (1) CA1222697A (fr)
CY (1) CY1689A (fr)
DE (2) DE3346123A1 (fr)
DK (1) DK175288B1 (fr)
FI (1) FI86140C (fr)
HK (1) HK131293A (fr)
HU (1) HU200943B (fr)
LU (1) LU90283I2 (fr)
NL (1) NL980009I1 (fr)
NO (1) NO2000007I1 (fr)
SG (1) SG24893G (fr)
WO (1) WO1985002767A1 (fr)
ZA (1) ZA8410042B (fr)

Families Citing this family (131)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920214A (en) * 1986-04-16 1990-04-24 American Maize-Products Company Process for producing modified cyclodextrins
JPH0819004B2 (ja) * 1986-12-26 1996-02-28 日清製粉株式会社 徐放性医薬製剤
IT1203968B (it) * 1987-04-24 1989-02-23 Bononi Ricerca Complessi di b-ciclodestrina ad attivita' antimicotica
NZ224497A (en) * 1987-05-18 1990-04-26 Janssen Pharmaceutica Nv Pharmaceutical composition comprising flunarizine
JP2577049B2 (ja) * 1987-06-04 1997-01-29 三共株式会社 シクロスポリン製剤
NZ225045A (en) * 1987-07-01 1990-06-26 Janssen Pharmaceutica Nv Antiviral pharmaceutical compositions containing cyclodextrin and an antiviral agent
ZA884592B (en) * 1987-08-31 1989-03-29 Warner Lambert Co Cyclodextrin complexes of bis-biguanido hexane compounds
US4877774A (en) * 1987-09-09 1989-10-31 The United States Of America As Represented By The Department Of Health And Human Services Administration of steroid hormones
US5256652A (en) * 1987-11-12 1993-10-26 Pharmedic Co. Topical compositions and methods for treatment of male impotence
FR2624731B1 (fr) * 1987-12-22 1992-10-23 Glaxo Group Ltd Compositions aqueuses contenant un derive de l'acide piperidinylcyclopentylheptenoique
US5221695A (en) * 1987-12-22 1993-06-22 Glaxo Group Limited Aqueous formulation containing a piperidinylcyclopentylheptenoic acid derivative and beta-cyclodextrin
US5017566A (en) * 1987-12-30 1991-05-21 University Of Florida Redox systems for brain-targeted drug delivery
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
DE68901043D1 (de) * 1988-01-14 1992-04-30 Akzo Nv Waessriges pharmazeutisches praeparat.
US5019562A (en) * 1988-01-19 1991-05-28 The Trustees Of The University Of Pennsylvania/Childrens Hospital Corporation Growth inhibiting agent and the use thereof
GR1000597B (el) * 1988-01-19 1992-08-26 Judah Moses Folkman Παραγοντας αναστολης αναπτυξης και χρηση του.
US5658894A (en) * 1989-04-23 1997-08-19 The Trustees Of The University Of Pennsylvania Compositions for inhibiting restenosis
US5637575A (en) * 1988-01-19 1997-06-10 The Trustees Of The University Of Pennsylvania Methods of inhibiting restenosis
US5760015A (en) * 1988-01-19 1998-06-02 The Trustees Of The University Of Pennsylvania Cyclodextrin compounds and methods of making and use thereof
AU626538B2 (en) * 1988-01-19 1992-08-06 Moses Judah Folkman Growth inhibiting agent and the use thereof
DE3809808A1 (de) * 1988-03-23 1989-10-05 Hexal Pharma Gmbh & Co Kg Feste, insbesondere festorale und rektale, etofenamat enthaltende arzneimittel
US5236944A (en) * 1988-03-28 1993-08-17 Janssen Pharmaceutica N.V. Compounds, compositions and anti-neoplastic methods
DE3815902A1 (de) * 1988-05-10 1989-11-23 Schwarz Pharma Gmbh Einschlussverbindungen des 1-(4-(2-(5-chloro-2-methoxybenzamido)ethyl) -phenylsulfonyl)-3-cyclohexylharnstoffs mit (alpha)-,ss-,(gamma)-cyclodextrinen, jeweils diese enthaltendes pharmazeutisches praeparat und verfahren zu deren herstellung
GB8813682D0 (en) * 1988-06-09 1988-07-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
NL8801670A (nl) 1988-07-01 1990-02-01 Walter Adrianus Josephus Johan Farmaceutisch preparaat.
US5229370A (en) * 1988-08-15 1993-07-20 Ammeraal Robert N Water soluble branched beta cyclodextrin steroid complex
EP0381747A4 (en) * 1988-08-15 1991-09-11 American Maize-Products Company Water soluble branched beta cyclodextrin steroid complex
MY106598A (en) * 1988-08-31 1995-06-30 Australian Commercial Res & Development Ltd Compositions and methods for drug delivery and chromatography.
US5997856A (en) * 1988-10-05 1999-12-07 Chiron Corporation Method and compositions for solubilization and stabilization of polypeptides, especially proteins
JP2929108B2 (ja) * 1988-10-28 1999-08-03 株式会社資生堂 化粧料および粉末化粧料
AU616571B2 (en) * 1988-10-28 1991-10-31 Shiseido Company Ltd. Cosmetic composition containing inclusion product with hydroxyalkylated cyclodextrin
IT1227626B (it) * 1988-11-28 1991-04-23 Vectorpharma Int Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
US5441944A (en) * 1989-04-23 1995-08-15 The Trustees Of The University Of Pennsylvania Substituted cyclodextrin sulfates and their uses as growth modulating agents
GB8910069D0 (en) * 1989-05-03 1989-06-21 Janssen Pharmaceutica Nv Method of topically treating acne vulgaris
JPH0737390B2 (ja) * 1989-08-29 1995-04-26 久光製薬株式会社 軟膏組成物
WO1991004026A1 (fr) * 1989-09-14 1991-04-04 Australian Commercial Research & Development Limited Compositions de liberation de medicaments
US5053240A (en) * 1989-10-24 1991-10-01 Kalamazoo Holdings, Inc. Norbixin adducts with water-soluble or water-dispersible proteins or branched-chain or cyclic polysaccharides
GB9001987D0 (en) * 1990-01-29 1990-03-28 Janssen Pharmaceutica Nv Improved cyclodextrin based erythropietin formulation
WO1991013100A1 (fr) * 1990-03-02 1991-09-05 Australian Commercial Research & Development Limited Compositions a base de cyclodextrines
FR2660309B1 (fr) * 1990-03-27 1992-07-17 Roussel Uclaf Nouveaux complexes de l'acide tiaprofenique ou de ses esters insolubles ou partiellement solubles avec les cyclodextrines ou leurs derives.
JP2867162B2 (ja) * 1990-03-31 1999-03-08 株式会社資生堂 ピールオフ型パック化粧料
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5120720A (en) * 1990-09-20 1992-06-09 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Preparation of lipophile:hydroxypropylcyclodextrin complexes by a method using co-solubilizers
LU87843A1 (fr) * 1990-11-15 1992-08-25 Cird Galderma Gel aqueux a base d'acide retinoique et d'hydroxypropyl-beta-cyclodextrine et son utilisation en medecine humaine et en cosmetique
JPH04351603A (ja) * 1991-05-29 1992-12-07 Toppan Printing Co Ltd β−シクロデキストリン誘導体
EP1004318A3 (fr) * 1991-06-21 2002-08-07 Takeda Chemical Industries, Ltd. Composition de cyclodextrin
US5446030A (en) * 1991-09-19 1995-08-29 Weisz; Paul B. Prevention of hemolysis
US5624914A (en) * 1991-10-16 1997-04-29 Schering Corporation Lipophilic oligosaccharide antibiotic salt compositions
IL103558A0 (en) 1991-10-30 1993-03-15 Schering Corp Tri-substituted tetrahydrofuran antifungals
US5254541A (en) * 1991-11-15 1993-10-19 Merck Frosst Canada, Inc. (Quinolin-2-ylmethoxy)indole/cyclodextrin complex
DE4207922A1 (de) * 1992-03-13 1993-09-23 Pharmatech Gmbh Wasserloesliche einschlussverbindungen und verfahren zu deren herstellung
US5472954A (en) * 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
DE4227569C1 (de) * 1992-08-20 1994-06-09 Inst Chemo Biosensorik Verfahren zum empfindlichen enzymatischen Nachweis von anorganischem Phosphat
TW251236B (fr) * 1992-09-10 1995-07-11 Ciba Vision Ag
JP2879395B2 (ja) * 1992-10-26 1999-04-05 富士写真フイルム株式会社 ロダシアニン化合物及びシクロデキストリンを含有する抗癌性組成物
US5494901A (en) * 1993-01-05 1996-02-27 Javitt; Jonathan C. Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent
WO1994020091A1 (fr) * 1993-03-05 1994-09-15 Hexal Pharma Gmbh Complexes cristallins d'insertion de cyclodextrine de l'hydrochlorure de ranitidine, et leur procede de preparation
CA2159717A1 (fr) * 1993-03-31 1994-10-13 Elliot Barnathan Methodes pour modifier la croissance des tissus vivants chez les mammiferes; composes et compositions utiles a cette fin
DK94093D0 (da) * 1993-08-17 1993-08-17 Finn Molke Borgbjerg Lokalanaestetisk praeparat
PH31594A (en) * 1993-09-30 1998-11-03 Janssen Pharmaceutica Nv Oral formulations on an antifungal.
CZ306394A3 (en) * 1993-12-14 1995-08-16 Lilly Co Eli Aqueous solution of inclusion complex of benzothiophene derivative with water-soluble cyclodextrins, process of its preparation and a pharmaceutical composition containing thereof
US5646131A (en) * 1994-02-22 1997-07-08 The Arab Company For Drug Industries And Medical Applicances (Acdima) Method for solubilizing drugs using cyclodextrins and carboxylic acids
WO1995025518A1 (fr) * 1994-03-18 1995-09-28 Ciba-Geigy Ag Solution aqueuse de levocabastine a usage ophtalmique
DE4414138A1 (de) * 1994-04-22 1995-10-26 Consortium Elektrochem Ind Acylierte gamma-Cyclodextrine
EP0760680A1 (fr) * 1994-05-27 1997-03-12 Farmarc Nederland Bv Compostion pharmaceutique
FR2726765B1 (fr) * 1994-11-14 1996-12-20 Cis Bio Int Compositions radiopharmaceutiques comprenant un complexe d'inclusion d'une cyclodextrine et d'un acide gras radiohalogene
US5576311A (en) * 1994-11-30 1996-11-19 Pharmos Corporation Cyclodextrins as suspending agents for pharmaceutical suspensions
FR2735136B1 (fr) * 1995-06-08 1997-08-14 Roquette Freres Composition pulverulente d'hydroxypropyl-betacyclodextrine et son procede de preparation.
JP2920611B2 (ja) * 1995-12-11 1999-07-19 株式会社シーエーシー 皮膚炎の治療外用剤
GB9605705D0 (en) 1996-03-19 1996-05-22 Pfizer Ltd Therapeutic agents
JP2000509374A (ja) 1996-04-19 2000-07-25 アルファ セラピュティック コーポレイション 凍結乾燥した血液タンパク質のウイルス不活性化方法
SE9601556D0 (sv) * 1996-04-24 1996-04-24 Astra Ab New pharmaceutical formulation of a thrombin inhibitor for parenteral use
EP0877600B1 (fr) * 1996-08-09 2003-10-22 Alcon Manufacturing Ltd. Systemes conservateurs pour compositions pharmaceutiques contenant des cyclodextrines
US5942501A (en) * 1996-08-16 1999-08-24 Collaborative Laboratories, Inc. Cyclodextrin derivative complex
EP0838225A3 (fr) * 1996-10-25 1999-03-24 Hiji, Yasutake Solution locale anesthétique aqueuse
JP3608800B2 (ja) * 1997-03-26 2005-01-12 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 抗真菌剤およびポリマーでコートされたコアを有するペレット剤
GB9713149D0 (en) 1997-06-21 1997-08-27 Pfizer Ltd Pharmaceutical formulations
AU9650398A (en) * 1997-11-07 1999-05-31 Daiichi Pharmaceutical Co., Ltd. Piperazine-cyclodextrin complexes
PT1039909E (pt) 1997-12-31 2003-02-28 Choongwae Pharma Corp Metodo de producao e composicao de uma preparacao oral de itraconazole
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
DE19848303A1 (de) * 1998-10-14 2000-04-20 Schering Ag Kombination aus Gestagenen und Zuckern
GB9906126D0 (en) * 1999-03-18 1999-05-12 Knoll Ag Pharmaceutical formulations
WO2001001955A1 (fr) * 1999-07-02 2001-01-11 Janssen Pharmaceutica N.V. Formulation comprenant un antifongique, a administrer par voie nasale
SE9902988D0 (sv) * 1999-08-24 1999-08-24 Astra Ab Chemical compounds
CN1223378C (zh) 2000-05-02 2005-10-19 施万制药 含有糖肽抗生素和环糊精的药物组合物
US6468989B1 (en) * 2000-07-13 2002-10-22 Dow Pharmaceutical Sciences Gel compositions containing metronidazole
PE20020300A1 (es) 2000-08-22 2002-05-10 Pharmacia Corp Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco
US6962944B2 (en) 2001-07-31 2005-11-08 Arqule, Inc. Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
US7074824B2 (en) 2001-07-31 2006-07-11 Arqule, Inc. Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
US6982256B2 (en) 2001-09-07 2006-01-03 Boehringer Ingelheim Pharma Kg Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administration
CA2463687A1 (fr) 2001-10-18 2003-04-24 Decode Genetics Ehf Complexes de non-inclusion a base de cyclodextrine
GB0127677D0 (en) * 2001-11-19 2002-01-09 Vianex S A Inclusion complex
US6881726B2 (en) 2001-12-24 2005-04-19 Dow Pharmaceutical Sciences Aqueous compositions containing metronidazole
MXPA04008171A (es) 2002-02-22 2004-11-26 Pharmacia Corp Formulacion oftalmica con sistema de goma.
US6951846B2 (en) * 2002-03-07 2005-10-04 The United States Of America As Represented By The Secretary Of The Army Artemisinins with improved stability and bioavailability for therapeutic drug development and application
US6818662B2 (en) 2002-05-28 2004-11-16 Taisho Pharmaceutical Co., Ltd. Pharmaceutical composition
DE10228049A1 (de) 2002-06-24 2004-01-15 Merck Patent Gmbh Flüssige Zubereitung enthaltend Oligopeptide
EP2272503B1 (fr) 2003-03-28 2013-03-20 Ares Trading S.A. Formulation orale de cladribine
KR20060011943A (ko) 2003-03-28 2006-02-06 아이박스 코포레이션 향상된 경구 및 경점막 수송용 클라드리빈 제형
US7888328B2 (en) 2003-03-28 2011-02-15 Ares Trading S.A. Oral formulations of cladribine
CN1294912C (zh) * 2004-03-01 2007-01-17 上海医药工业研究院 伊曲康唑盐酸盐组合物及其冻干粉针
DE102004011512B4 (de) 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
EP1579862A1 (fr) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Utilisation des inhibiteurs de PDE III pour la réduction de la taille du coeur chez des mammifères souffrant d'insufficances cardiaques
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
ITMI20041763A1 (it) * 2004-09-16 2004-12-16 Altergon Sa Nuove formulazioni iniettabili contenenti progesterone
WO2006137433A1 (fr) * 2005-06-21 2006-12-28 Wakamoto Pharmaceutical Co., Ltd. Préparation aqueuse comprenant de la levocabastine solubilisée
US7744904B1 (en) 2005-09-26 2010-06-29 B.B. Scientific L.L.C. Stabilization of Clostridium botulinum neurotoxin complex
US20100038816A1 (en) 2006-08-16 2010-02-18 Novartis Ag Method of making solid dispersions of highly crystalline therapeutic compounds
BRPI0717460A2 (pt) * 2006-10-20 2013-12-24 Icos Corp Composições de inibidores de chk1
EP1920785A1 (fr) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Préparation liquide contenant un complexe du pimobendane et de la cyclodextrine
US20100056500A1 (en) * 2006-11-21 2010-03-04 Thitiwan Buranachokaisan Stable Parenteral Formulation
AU2009217969A1 (en) * 2008-02-28 2009-09-03 Takeda Pharmaceutical Company Limited Pharmaceutical composition
BRPI0921868A2 (pt) 2008-11-25 2015-12-29 Boehringer Ingelheim Vetmed inibidores de fosfodiesterase tipo iii (pde iii) ou agentes de sensibilizacao de ca2+ para o tratamento de cardiomiopatia hipertrofica
WO2010088924A1 (fr) 2009-02-06 2010-08-12 Telormedix Sa Compositions pharmaceutiques comprenant des imidazoquinolines (amines) et des dérivés de celles-ci appropriés pour une administration locale
CN102499909B (zh) * 2011-12-27 2013-08-07 哈尔滨三联药业有限公司 伊曲康唑分散片及其制备方法
KR101383941B1 (ko) * 2012-03-09 2014-04-10 동아에스티 주식회사 피록시캄 또는 약제학적으로 허용되는 그의 염과 히알루론산 또는 약제학적으로 허용되는 그의 염의 안정한 액상 조성물 및 그 제조방법
US10398705B2 (en) 2012-03-15 2019-09-03 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
CA2877724A1 (fr) * 2012-06-28 2014-01-03 Der-Yang Lee Compositions liquides de racecadotril
SG10201707618TA (en) * 2013-03-13 2017-10-30 Seattle Genetics Inc Cyclodextrin and antibody-drug conjugate formulations
WO2015007760A1 (fr) 2013-07-19 2015-01-22 Boehringer Ingelheim Vetmedica Gmbh Composition pharmaceutique aqueuse liquide contenant des dérivés de cyclodextrine éthérifiés conservés
EP3054980B1 (fr) * 2013-10-08 2019-09-04 InnoPharma, Inc. Formulations liquides orales d'aprépitant
CN110721164A (zh) 2013-12-04 2020-01-24 勃林格殷格翰动物保健有限公司 匹莫苯的改善的药物组合物
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
JP2020526501A (ja) * 2017-06-30 2020-08-31 セルジーン コーポレイション ２−（４−クロロフェニル）−ｎ−｛［２−（２，６−ジオキソピペリジン−３−イル）−１−オキソイソインドリン−５−イル］メチル｝−２，２−ジフルオロアセトアミドの組成物及び使用法
US10716774B1 (en) 2018-01-05 2020-07-21 Yale Pharmaceuticals LLC Pharmaceutical compositions containing isotretinoin with improved dissolution profile and enhanced stability
CN112334494A (zh) * 2018-06-29 2021-02-05 罗盖特公司 新颖的羟丙基-β-环糊精及其生产方法
FR3083234B1 (fr) * 2018-06-29 2020-11-27 Roquette Freres Nouvelles hydroxypropyl-beta-cyclodextrines et leurs procedes de preparation
CN112996562A (zh) 2018-10-29 2021-06-18 赛克洛治疗股份有限公司 治疗阿尔茨海默病的方法
CN114195733A (zh) * 2022-01-07 2022-03-18 华东理工大学 一种抑制烯丙苯噻唑异构化的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459731A (en) * 1966-12-16 1969-08-05 Corn Products Co Cyclodextrin polyethers and their production
US3453259A (en) * 1967-03-22 1969-07-01 Corn Products Co Cyclodextrin polyol ethers and their oxidation products
HU181703B (en) * 1980-05-09 1983-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents
US4371673A (en) * 1980-07-21 1983-02-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble forms of retinoids

Also Published As

Publication number Publication date
ZA8410042B (en) 1985-09-25
NO2000007I1 (no) 2000-09-21
SG24893G (en) 1993-08-06
DK359585D0 (da) 1985-08-07
DK359585A (da) 1985-08-07
JPS61500788A (ja) 1986-04-24
AU565966B2 (en) 1987-10-01
AU3835285A (en) 1985-07-12
LU90283I2 (fr) 1998-11-03
DK175288B1 (da) 2004-08-09
ATE51145T1 (de) 1990-04-15
EP0149197B2 (fr) 1997-01-08
FI853198L (fi) 1985-08-20
WO1985002767A1 (fr) 1985-07-04
FI853198A0 (fi) 1985-08-20
FI86140B (fi) 1992-04-15
DE3346123A1 (de) 1985-06-27
CA1222697A (fr) 1987-06-09
CY1689A (en) 1994-01-14
EP0149197B1 (fr) 1990-03-21
HU200943B (en) 1990-09-28
NL980009I1 (nl) 1998-05-06
EP0149197A3 (en) 1985-08-14
FI86140C (fi) 1992-07-27
JPH0570612B2 (fr) 1993-10-05
EP0149197A2 (fr) 1985-07-24
DE3481680D1 (de) 1990-04-26
HUT40561A (en) 1987-01-28

Similar Documents

Publication Publication Date Title
ZA8410042B (en) Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation
IL89503A0 (en) Taxol derivatives,pharmaceutical compositions containing the same and process for the preparation thereof
IL77133A (en) Antineoplastic pharmaceutical compositions containing pentofuranoside derivatives,some new such compounds and their preparation
IL72854A (en) 1-heteroaryl-4-((2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives,their preparation and pharmaceutical compositions containing them
IL88765A (en) N-hydroxycycloalkyl or n-hydroxycycloalkenyl- substituted adenosine derivatives, methods for their preparation and pharmaceutical compositions, including antilipolytic compositions, containing the same
IL71249A0 (en) Thiazolidine derivatives,their preparation and pharmaceutical compositions containing them
IL73332A0 (en) Triazine derivatives,their preparation and pharmaceutical compositions containing them
IL66434A0 (en) Thiazolidinylalkylene piperazine derivatives,their preparation and pharmaceutical compositions containing them
DE3886298T2 (de) Aralkylaminalkoxyphenyl-Derivate, Verfahren zur Herstellung und sie enthaltende Zusammensetzungen.
ATE70056T1 (de) Oxopyrimidin-derivate und sie enthaltende pharmazeutische zubereitungen.
IL68011A0 (en) Cephalosporin derivatives,their preparation and pharmaceutical compositions containing them
SE8302979L (sv) Piperazinderivat, deras framstellning och farmaceutiska kompositioner innehallande dessa
IL62229A0 (en) Heterocyclic derivatives,their preparation and pharmaceutical compositions containing them
IL73902A (en) Gonadoliberin derivatives,their preparation and pharmaceutical compositions containing them
SE8306225L (sv) 2-piperazinyl-kinazolinderivat, deras framstellning och farmaceutiska kompositioner innehallande desamma
DE3060669D1 (en) Phenylalanyl-tryptophan derivatives, pharmaceutical compositions containing them, their preparation and use
IL66433A0 (en) Spirothiazolidinyl piperazine derivatives,their preparation and pharmaceutical compositions containing them
IL72480A0 (en) Benzamidine derivatives,their preparation and pharmaceutical compositions containing them
IL63783A0 (en) Phenyl piperazine derivatives,their preparation and pharmaceutical compositions containing them
IL84665A0 (en) Azole derivatives,their preparation and pharmaceutical compositions containing them
IT8022188A0 (it) Derivati nicotinici di glucosamina, procedimento per la preparazione e relative composizioni farmaceutiche.
IL67990A0 (en) Heterocyclic derivatives,their preparation and pharmaceutical compositions containing them
IL87975A (en) Cephalosporin derivatives, their preparation and pharmaceutical compositions containing them
IL84129A (en) Bis(2,2-dialkylalkanoyl)-3-(4-trialkylbenzyl)-1-piperazinyl)-rifamycin s derivatives,their preparation and pharmaceutical compositions containing them
IL66812A0 (en) Cephalosporin derivatives,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20041219